Clinical Trial Update: Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating stereotactic photodynamic therapy with Gliolan (5-aminolevulinic acid) for adults with recurrent glioblastoma; the study has been termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Gliolan (5-aminolevulinic acid)

Snippet

Sponsor: University Hospital Muenster | Conditions: Glioblastoma Multiforme, Adult | Phase 2 | Status: TERMINATED